In addition, many anti-inflammatory strategies have had only modest effects at modulating insulin resistance and glucose regulation, lipid accumulation in the liver, or the progression from NAFLD to NASH and fibrosis [3, 109]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.